|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Parotid-sparing in- tensity modulated versus conventional radiotherapy in head and neck cancer ( PARSPORT ) : a phase 3 muhicentre randomised controlled trial 显示文摘 | Nutting CM Morden JP Harrington KJ | 2011 | Lancet Oncol2011，12，2： | 1 |
| 2 | Sorafenib in radioactiveiodine-refractory,locally advanced or metastatic differentiatedthyroid cancer: a randomised, double-blind, phase 3 trial 显示文摘 | Brose MS Nutting CM Jarzab B | 2014 | Lancet2014，384，9940： | 1 |
| 3 | A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy显示文摘 | Nutting CM Bedford JL Cosgrove VP | 2001 | Radiother Oncol2001，61，2： | 1 |
| 4 | A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy显示文摘 | Nutting CM Bedford JL Cosgrove VP | 2001 | Radiother Oncol2001，61，2： | 1 |
| 5 | Transformation to 'high grade' neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma显示文摘 | POPAT S WOTHERSPOON A NUTTING CM | 2013 | Lung Cancer2013，80，1： | 1 |
| 6 | Rationale and design of decision:a double-blind,randomized,placebo-controlled phase Ⅲtrial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory,differentiated thyroid cancer显示文摘 | Brose MS Nutting CM Sherman SI | | 0，，： | 1 |
| 7 | A comparison of confor-mal and intensity - modulated techniques for oesophageal radiotherapy显示文摘 | Nutting CM Bedford JL Cosgrove VP | 2001 | Radiother Oncol2001，61，2： | 1 |
| 8 | large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer 显示文摘 | Nutting CM ConveryReduction of small and D J Cosgrove VP | 2000 | Int J Radiat Oncol Biol Phys2000，48，： | 1 |
| 9 | A comparison of conformal and intensity - modulated techniques for oesophageal radiotherapy 显示文摘 | Nutting CM Bedford JL Cosgrove VP | 2001 | Radiother Oncol2001，61，： | 1 |
| 10 | Treatmentrelateddysgeusia in head and neck cancer patients 显示文摘 | Irune E Dwivedi RC Nutting CM | 2014 | Cancer Treat Rev2014，40，9： | 1 |
| 11 | Beam-orientation optimization of intensity-modulated radiotherapy: clinical application to parotid gland tumours 显示文摘 | Rowbottom CG Nutting CM Webb S | 2001 | Radiother Oncol2001，59，2： | 1 |
| 12 | A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy显示文摘 | Nutting CM Bedford JL Cosgrove VP | | 0，，： | 1 |
| 13 | Rationale and design ofdecision : a double - blind,randomized, placebo - controlled phaseIII trial evaluating the efficacy and safety of sorafenib in patientswith locally advanced or metastatic radioactive iodine ( RAI) - re-fractory ,differentiated thyroid cancer 显示文摘 | Brose MS Nutting CM Sherman SI | 2011 | BMC Cancer2011，11，： | 1 |
| 14 | Evaluation of intensity modulated radiotherapy for tumors of the pelvis and head and neck and thorax optimization and clinical implementation 显示文摘 | Rowbottom C Cosgrove UP | 2000 | Int J Radiat Oncol Biol Phys2000，48，3： | 1 |
| 15 | Sorafenib in radioac- tiveiodine-refractory, locally advanced or metastaticdifferentiated thyroid cancer: a randomised, double-blind, phase 3 trial显示文摘 | Brose MS Nutting CM Jarzab B | 2014 | Lancet2014，384，9940： | 1 |
| 16 | Primary orbital lymphoma 显示文摘 | Nutting CM Jenkins CD Norton AJ | 2002 | Hematol J2002，3，1： | 1 |
| 17 | Sorafenib in radioactive i- odine-refractory, locally advanced or metastatic differentiated thy- roid cancer: a randomized, double-blind, phase 3 trial显示文摘 | Brose MS Nutting CM Jarzab B | 2014 | Lan- cet2014，384，7： | 1 |
| 18 | A comparison of conformal and intensity modulated techniques for oesoph- ageal radiothcrapy显示文摘 | Nutting CM Bcdford JL Cosgrovc VP | 2001 | Radiother Oncol2001，61，： | 1 |
| 19 | Sorafenih in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 显示文摘 | Brose MS Nutting CM Jarzab B | 2014 | Lancet2014，384，9940： | 1 |
| 20 | Sorafenib in radioactive i- odine-refractory, locally advanced or metastatic differentiated thy- roid cancer: a randomised, double-blind, phase 3 trial 显示文摘 | Brosc MS Nutting CM Jarzab B | 2014 | Lan- cet2014，384，9940： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员